During the past decade, Moscow Endocrinological Dispensary conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Moscow Endocrinological Dispensary" are "Diabetes Mellitus, Type 2" (2 trials) and "Diabetes Mellitus" (1 trials). Many other conditions were trialed in "Moscow Endocrinological Dispensary" in a lesser frequency.

Most popular intervention types in "Moscow Endocrinological Dispensary" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Humalog Mix25" (1 trials), "Insulin Humulin® NPH" (1 trials), "Insulin Lispro Biphasic 25" (1 trials) and "Insulin Rinsulin® NPH" (1 trials). Other intervention names were less common.

The vast majority of trials in "Moscow Endocrinological Dispensary" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Moscow Endocrinological Dispensary". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Moscow Endocrinological Dispensary, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Moscow Endocrinological Dispensary, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".